1 day ago
1
Reuters
Tue, February 3, 2026 astatine 6:00 AM CST 1 min read
Feb 3(Reuters) - Pfizer connected Tuesday reported fourth-quarter nett supra Wall Street estimates, as sustained request for older drugs specified as humor thinner Eliquis helped offset fading income of its COVID products.
The upbeat results onshore arsenic Pfizer navigates falling request for its COVID-19 products and faces the upcoming patent expirations connected several of its older drugs, which volition let cheaper generics to participate the market.
NYSE - Delayed Quote USD
26.66 +0.22 (+0.83%)
At close: February 2 astatine 4:00:02 PM EST
Pfizer has already warned of challenges it expects implicit the adjacent fewer years and has said that it does not expect to instrumentality to gross growth until 2029. The institution is banking connected processing caller blockbuster medicines, including obesity drugs acquired done caller deals, to assistance thrust that recovery.
Robust request for its bosom and oncology drugs helped execute total income for the 4th of $17.56 billion, compared with analysts' mean anticipation of $16.95 billion, according to information compiled by LSEG.
On an adjusted basis, the institution reported a nett of 66 cents per share, compared to analysts estimates of 57 cents per share.
(Reporting by Sneha S K successful Bengaluru; Editing by Anil D'Silva)
English (CA) · 
English (US) · 
Spanish (MX) ·